【Spotlight】A Milestone in Taiwan's Precision Cancer Treatment: NYCU Outstanding Alumnus Archie Hwang Donates NT$1.2 Billion ABBNCT Equipment, Boosting Cancer Care

Full metadata record

DC Field	Value	Language
dc.contributor.author	國際事務處	zh_TW
dc.contributor.author	Office of International Affairs	en_US
dc.date.accessioned	2024-12-09T06:19:59Z	-
dc.date.available	2024-12-09T06:19:59Z	-
dc.date.issued	2024-10-28	en_US
dc.identifier.uri	https://www.nycu.edu.tw/nycu/en/app/news/view?module=headnews&id=552&serno=f41aadfa-84d4-4d40-b4cc-46b0bd0e86ab	en_US
dc.identifier.uri	http://hdl.handle.net/11536/163324	-
dc.description.abstract	Mr. Archie Hwang, an outstanding alumnus of National Yang Ming Chiao Tung University (NYCU) and founder and chairman of Hermes-Epitek Corporation, generously donated accelerator-based Boron Neutron Capture Therapy (AB-BNCT) equipment developed by Heron Neutron Medical Corp.	en_US
dc.language.iso	en_US	en_US
dc.publisher	國立陽明交通大學	zh_TW
dc.publisher	National Yang Ming Chiao Tung University	en_US
dc.title	【Spotlight】A Milestone in Taiwan's Precision Cancer Treatment: NYCU Outstanding Alumnus Archie Hwang Donates NT$1.2 Billion ABBNCT Equipment, Boosting Cancer Care	en_US
dc.type	Historical News	en_US
dc.identifier.journal	陽明交大英文電子報	zh_TW
dc.identifier.journal	NYCU E-NEWS	en_US
dc.citation.issue	2024-10	en_US
Appears in Collections:	NYCU E-NEWS

Files in This Item:

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.